MGX

METAGENOMI THERAPEUTICS INC

MGX·59102M104·US·Common Stock·Healthcare - Biotechnology

MGX (METAGENOMI THERAPEUTICS INC) is held by 34 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.4M), RENAISSANCE TECHNOLOGIES LLC ($1.1M), TWO SIGMA INVESTMENTS, LP ($665,668). Net institutional sentiment: Mixed.

34
Holders
Avg rating(8 Elite)
$6M
Total Value
40% (40)
Fund Consensus
12 buying - 18 selling
MGXSmart Money Verdict
View all
Held by 34 funds
8 elite
Who's Trading
InsiderIJIrish JianSell $5KJun 5, 2026
InsiderWPWapnick PamelaSell $4KJun 5, 2026
InsiderWMWein MatthewSell $724.84Jun 5, 2026
InsiderIJIrish JianSell $3KMar 5, 2026
InsiderWPWapnick PamelaSell $3KMar 5, 2026
InsiderWMWein MatthewSell $771.2Mar 5, 2026
InsiderTCThomas Brian C.Sell $7KDec 5, 2025
InsiderIJIrish JianSell $3KDec 5, 2025
InsiderWPWapnick PamelaSell $3KDec 5, 2025
InsiderWMWein MatthewSell $352.61Dec 5, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.1M$1.4M0.0%-15.89%
39
Increased
787,900(+25.4%)$1.1M0.0%-25.27%
31
Increased
496,767(+12.6%)$665,6680.0%-33.11%
28
New
382,153$512,0850.0%-15.89%
33
Increased
358,200(+17.1%)$480,1570.0%-64.99%
19
Increased
230,134(+2.7%)$308,3790.0%-61.92%
16
Increased
202,138(+70.7%)$270,8650.0%-56.97%
35
New
170,174$228,0330.0%-15.89%
32
Decreased
170,104(-27.7%)$227,9390.0%-26.69%
0
Decreased
151,440(-65.1%)$202,9290.0%-19.02%
0
Unchanged
120,427$161,3720.0%-58.45%
0
Increased
78,636(+39.2%)$105,3720.0%-37.91%
29
Unchanged
75,172$100,7300.0%-51.89%
0
Decreased
40,582(-41.2%)$54,3800.0%-27.61%
0
Decreased
27,566(-53.8%)$36,9380.0%-58.42%
0
Decreased
27,521(-65.2%)$36,8780.0%-13.01%
0
Decreased
16,993(-90.5%)$22,7710.0%-20.63%
0
Increased
16,834(+49.0%)$22,5580.0%-19.13%
18
Decreased
16,098(-35.9%)$21,5710.0%-40.40%
0
New
13,392$17,9450.0%-15.89%
28

Showing 1-20 of 40

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used